World Markets
ALK

U.S. STOCKS ON THE MOVE-Nike, Anadarko, Walt Disney, JPMorgan

Reuters

The Day Ahead newsletter:

The Morning News Call newsletter:

At 8:00 ET, Dow e-minis were up 0.70 percent at 26,315. S&P 500 e-minis were up 0.50 percent at 2,906.25, while Nasdaq 100 e-minis were up 0.41 percent at 7,648.5.

The top three NYSE percentage gainers premarket :

** Anadarko Petroleum Corp , up 31.2 pct

** Qudian Inc , up 9.5 pct

** Laredo Petroleum Inc , up 8.4 pct

The top two NYSE percentage losers premarket :

** Four Seasons Education (Cayman) Inc , down 7.3 pct

** Resideo Technologies Inc , down 7.3 pct

The top three Nasdaq percentage gainers premarket :

** Vantage Energy Acquisition Corp , up 100.0 pct

** Vital Therapies Inc , up 53.2 pct

** Taronis Technologies Inc , up 41.5 pct

The top three Nasdaq percentage losers premarket :

** Reebonz Holding Limited , down 50.9 pct

** Tracon Pharmaceuticals Inc , down 49.1 pct

** X4 Pharmaceuticals Inc , down 27.8 pct

** Anadarko Petroleum Corp : up 31.2 pct premarket

Anadarko Petroleum: Jumps as Chevron swoops in with $33 bln deal

** JPMorgan & Chase Co : up 2.6 pct premarket

JPMorgan shares add to gain after better-than-expected Q1 results

** Walt Disney Co : up 5.4 pct premarket

Disney: Shares advance after aggressive streaming push

** Nike Inc : up 0.6 pct premarket

Nike: Olympics 2020 sales to be a positive catalyst - JP Morgan

** X4 Pharmaceuticals Inc : down 27.8 pct premarket

X4 Pharmaceuticals: Slides on stock-and-warrants offering plan

** Alaska Air Group Inc : up 1.1 pct premarket

Alaska Air Group: Up after raising Q1 unit revenue outlook

** Allegheny Technologies Inc : down 3.8 pct premarket

Allegheny Technologies: Down after flagging Q1 profit below estimates

** Mosaic Co : down 1.9 pct premarket

Mosaic: Dips on halting Brazil production following new rules around dams

** X4 Pharmaceuticals Inc : down 27.8 pct premarket

X4 Pharma: Drops on planned deep-discounted equity raise

** Amyris Inc : down 20.4 pct premarket

Amyris: Slumps after disclosing accounting errors

** TRACON Pharmaceuticals Inc : down 49.1 pct premarket

Tracon Pharma tumbles after terminating late-stage cancer study


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ALK

Other Topics

US Markets Oil Stocks

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More